Dare Bioscience Statistics
NASDAQ: DAREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.7722-0.0178 (-2.25%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Dare Bioscience by the numbers
Dare Bioscience has a market capitalization of $15.2 million based on 19.67M shares outstanding. With trailing EPS of $-0.71, Dare Bioscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.3% below its 50-day average and 54.4% below its 200-day average.
Average daily trading volume is 524.37K shares, or about $404,916 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DARE valuation vs. peer median
| Metric | DARE | Peer median | Difference |
|---|---|---|---|
| Market cap | $15.19M | $15.98M | -5% |
| Avg. volume | 524.37K | 241.22K | +117% |
Peer median across 8 companies: AEON, ALLR, MRKR, LPCN, PTN, RKTO, RADX, ACTU.
Valuation
- Market cap
- $15.19M
- EPS (TTM)
- $-0.71
- Shares outstanding
- 19.67M
Price and trading
- Previous close
- 0.79
- Open
- 0.7862
- Day range
- 0.755 – 0.80
- 52-week range
- 0.69 – 3.78
- 52-week change
- -64.81%
- 50-day moving average
- 0.9112
- Beta
- —
- Volume
- 165.79K
- Average volume
- 524.37K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 15.19M
- Forward Pe
- -1.86
- Eps
- -0.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.78
- Week52 Low
- 0.69
- Avg Volume
- 524.37K
- Shares Outstanding
- 19.67M
- Ma50
- 0.91
- Ma200
- 1.69
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -79.57%
- Pct From52w Low
- 11.91%